Available Until 4/5/2026

Implementing Terlipressin at a Large Health System

Planned in cooperation with the ASHP SICP ESC

ACPE Activity Number: 0204-0000-23-082-H01-P
Release Date: 4/05/2023
Expiration Date: 4/05/2026 
Activity Type: Knowledge-based 
CE Credits:  1.0 contact hour, (0.10 CEU)
Activity Fee: Member – Free / Non-Member – Not Available 

This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview 

Speakers will share the development journey of terlipressin implementation in a large health system including their experience with developing interdisciplinary usage guidelines, implementing education for pharmacy and nursing, and organizing a prospective monitoring plan, in collaboration with specialist providers and nursing. 

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This activity was planned to meet the educational needs of pharmacists that are considering implementing terlipressin at their practice site.  

After completing this activity, the learner should be able to… 

1. Define the place of terlipressin in therapy.  

2. Discuss usage criteria for terlipressin at your organization.  

3. Identify interdisciplinary collaborators for terlipressin usage guideline implementation. 

  • Introduction and Announcements 

  • Presentation  

  • Questions, Answers, and Discussion 

Andreea E. Popa, PharmD, BCPS, BCCCP
Clinical Pharmacy Specialist 
University Hospitals Cleveland Medical Center 
Cleveland, OH

Maribel Llamas Rangel, PharmD, BCCCP
Clinical Pharmacy Specialist 
University Hospitals Cleveland Medical Center
Cleveland, OH

Jason Patton, PharmD
PGY1 Pharmacy Practice Resident
University Hospitals Cleveland Medical Center
Cleveland, OH

Indrani Kar, PharmD, DPLA
System Pharmacy Manager, Formulary and Drug Policy
University Hospitals Health System
Cleveland, OH

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.